Eir Ventures have lead the funding round in Synklino, an innovative Biotech company that develops new first in class therapies for viral infections

Synklino is a Danish biotech company with technology from the University of Copenhagen and the Technical university of Denmark, focusing on developing groundbreaking therapies against devastating virus infections.

Eir Ventures is happy to announce that we have lead the funding round in Synklino, an innovative Biotech company that develops new first in class therapies for viral infections. This commitment is also the first under our Seedling program, that aims to provide financing to exceptional start-up companies from Nordic Universities and Incubators.

Click here to download this Press Release as PDF